40 participants
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2026-05-05
- Completion:
- 2027-09-30
Conditions
- Alpha 1 Antitrypsin Deficiency
Interventions
- DRUG
- OTHER
No Results Yet